Vimarsana
Biggest News Aggregation in the World

Page 25 - New Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Technologies Today - Breaking & Trending Today

GA-ASI completes first full-scale fatigues test on MQ-9B - Vimarsana News

GA-ASI completes first full-scale fatigues test on MQ-9B

General Atomics Aeronautical Systems, Inc. (GA-ASI) recently completed the “first lifetime” of fatigue testing – which is equivalent to 40,000 operating hours – and represents an important step in validating the design of the airframe system.

GA-ASI uses autonomy to close F2T2EA engagement chain - Vimarsana News

GA-ASI uses autonomy to close F2T2EA engagement chain

General Atomics Aeronautical Systems, Inc. (GA-ASI) demonstrated its rapidly maturing open standards-based autonomy ecosystem for Unmanned Combat Air Vehicles (UCAVs) on an MQ-20 Avenger® as part of a live flight test on Nov. 2, 2023.

Draper wins $26M Pentagon contract for remote CBRN detection - Vimarsana News

Draper wins $26M Pentagon contract for remote CBRN detection

Draper announced it has been awarded a $26 million contract by the U.S. Department of Defense to further expand the capabilities of its UAS software to perform reconnaissance missions in collaborative teams and degraded operating environments.

AeroVironment announces successful GPS-guided Shryke munitions - Vimarsana News

AeroVironment announces successful GPS-guided Shryke munitions

AeroVironment, Inc. announced the first successful multi-drop, live fire GPS-guided Shryke munitions from the VAPOR® 55 MX, all-electric unmanned aircraft system in collaboration with Corvid and L3Harris Technologies.

BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference

Plans to have ten or more potentially registrational trials by the end of 2024 Preparing to be commercial-ready by the end of 2025 Ended 2023 with approximately €17.5 billion in cash, cash...